Bio Therapeutic Drugs Company Equity Stake For Sale in Sydney, Australia
Biotech with a novel recombinant protein injection to cure back pain seeking seed investment.
Premium Plan
| Established | 1-5 year(s) |
| Employees | 2 - 5 |
| Legal Entity | Private Limited Company |
| Reported Sales | Nil |
| Run Rate Sales | Nil |
| EBITDA Margin | Nil |
| Industries | Bio Therapeutic Drugs |
| Locations | Sydney |
| Local Time | 5:07 PM Australia / Sydney |
| Listed By | Business Owner / Director |
| Status | Active |
Partial Stake Sale
USD
10 million
for
35.0%
stake
(Native Currency: AUD 15,190,000)
Reason: A$11M has been spent on getting to high tech recombinant protein manufacture and animal research. Th...
View More
Interested to connect with advisors
Name, Phone, Email
Available after connect
Business Name
Available after connect
User Verification
Documents
Business Overview
- Our groundbreaking recombinant formulation induces stem cell recruitment and differentiation, stimulating intervertebral disc cell matrix for regeneration and self-healing.
- Developed as an image-guided intra-disc administration under local anesthesia, ensuring precision and effectiveness in the therapeutic process.
- A therapeutic candidate for the regeneration of spinal intervertebral discs in patients with debilitating degenerative disc conditions.
- Induces the mobilization and differentiation of stem cells, leading to de novo regeneration of intervertebral discs and stabilization of the affected spine.
- Backed by a compelling biological rationale and a robust preclinical data set, demonstrating a strong proof of concept.
- Cure back pain with personalized, targeted, regenerative therapy via a non-invasive injection directly into the disc.
- Offers a cost-effective and quick procedure, aiming to enhance the quality of life for patients.
- Positioned in the $300 billion back pain industry, addressing a significant market need.
- Great investment opportunity at the seed stage, with RDTI registration in Australia reflecting a commitment to research and development.
- Administered as a convenient day procedure service, either in a radiology suite or a day procedure facility.
- Founded by individuals with decades of experience in the industry.
- Developed as an image-guided intra-disc administration under local anesthesia, ensuring precision and effectiveness in the therapeutic process.
- A therapeutic candidate for the regeneration of spinal intervertebral discs in patients with debilitating degenerative disc conditions.
- Induces the mobilization and differentiation of stem cells, leading to de novo regeneration of intervertebral discs and stabilization of the affected spine.
- Backed by a compelling biological rationale and a robust preclinical data set, demonstrating a strong proof of concept.
- Cure back pain with personalized, targeted, regenerative therapy via a non-invasive injection directly into the disc.
- Offers a cost-effective and quick procedure, aiming to enhance the quality of life for patients.
- Positioned in the $300 billion back pain industry, addressing a significant market need.
- Great investment opportunity at the seed stage, with RDTI registration in Australia reflecting a commitment to research and development.
- Administered as a convenient day procedure service, either in a radiology suite or a day procedure facility.
- Founded by individuals with decades of experience in the industry.
Products & Services Overview
Biotech with a novel recombinant protein injection to cure back pain.
Assets Overview
Issued patents; Trade secret IP around manufacturing,New IP generation via contracted university research.
Facilities Overview
Use global contractors for manufacturing and regulatory support. We have rented facilities in India and Korea. The details of the facility will be disclosed after introduction.
Capitalization Overview
Four shareholders including inventors and a strategic partner. No loans. Company registered for tax incentives. Selling equity to fund regulatory approval.
Recent Activity
-
Earlier than 15 daysBusiness Consultant & Advisor, Trading, Jakarta, Corporate Investor / Buyer connected with the Business
-
Earlier than 15 daysManaging Director, Aviation, Aerospace &Defence, Hyderabad, Corporate Investor / Buyer connected with the Business
Tags:
Bio Therapeutic Drugs Company Investment Opportunity in Sydney, Australia
·Invest in Bio Therapeutic Drugs Company in Sydney, Australia
·Bio Therapeutic Drugs Company Investment Opportunity
·Investment Opportunity in Sydney, Australia
·Invest in Bio Therapeutic Drugs Company
·Invest in Sydney, Australia
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
Contact Business
4 Investors already contacted this Business.
Register below to connect now!
- Social
- Register
- Login
Who uses SMERGERS?
... and 64,000+ other businesses of all sizes.
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct.
You might also be interested in these businesses